One of the highlights of the recent International Conference on the Science of Botanicals (ICSB), an annual event hosted by the National Center for Natural Products Research (NCNPR), was a presentation on new kava research by Chris Xing, Ph.D., an assistant professor of medicinal chemistry at the University of Minnesota. INSIDER TV talked to Dr. Xing about what this new knowledge could mean for the kava supplement market. He discusses the difference between cultivars and highlights some of the key study results that show the right kind of kava is safe for regular consumption.
Natural Products Insider is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.